Based on available data, no major side effects or safety issues are currently reported
Loss of SMAD4 occurs in more than 50% of PDAC patients [106, 107]
This therapy stimulates collagen production, reduces inflammation, and accelerates recovery in joints, tendons, and ligaments
Most peptides obtained outside of a clinical trial or compounding pharmacy setting cannot be guaranteed sterile, pure, or bioactive. CSMR, 2018 Risks of Injecting an Unregulated Compound Patients often reconstitute BPC157 at home using bacteriostatic water (often purchased separately), without understanding: Sterile technique standards are not being met
David Perlmutters research on alterations in glutathione levels, there seems to be both a clinical and neuropathological difference in PD patients treated with IV glutathione versus control groups
However, its still emerging in the research field, with limited human studies to back its efficacy